Previous studies suggested that NDRG1 could inhibit proliferation and induce apoptosis of cancer cells by regulating Bcl-2 and Ca2+-associated proteins (30, 31) and epithelial–mesenchymal transition (EMT) (32). Here, BCL2 is linked to cancer.